These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26101715)

  • 1. Genetic alterations of KDM4 subfamily and therapeutic effect of novel demethylase inhibitor in breast cancer.
    Ye Q; Holowatyj A; Wu J; Liu H; Zhang L; Suzuki T; Yang ZQ
    Am J Cancer Res; 2015; 5(4):1519-30. PubMed ID: 26101715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone lysine demethylase (KDM) subfamily 4: structures, functions and therapeutic potential.
    Labbé RM; Holowatyj A; Yang ZQ
    Am J Transl Res; 2013; 6(1):1-15. PubMed ID: 24349617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.
    Chin YW; Han SY
    Expert Opin Ther Pat; 2015 Feb; 25(2):135-44. PubMed ID: 25468267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in histone demethylase KDM4 as cancer therapeutic targets.
    Lee DH; Kim GW; Jeon YH; Yoo J; Lee SW; Kwon SH
    FASEB J; 2020 Mar; 34(3):3461-3484. PubMed ID: 31961018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncogenic potential of Jumonji D2 (JMJD2/KDM4) histone demethylase overexpression.
    Young LC; Hendzel MJ
    Biochem Cell Biol; 2013 Dec; 91(6):369-77. PubMed ID: 24219278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The JmjN domain as a dimerization interface and a targeted inhibitor of KDM4 demethylase activity.
    Levin M; Stark M; Assaraf YG
    Oncotarget; 2018 Mar; 9(24):16861-16882. PubMed ID: 29682190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells.
    Berry WL; Janknecht R
    Cancer Res; 2013 May; 73(10):2936-42. PubMed ID: 23644528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TACH101, a first-in-class pan-inhibitor of KDM4 histone demethylase.
    Chandhasin C; Dang V; Perabo F; Del Rosario J; Chen YK; Filvaroff E; Stafford JA; Clarke M
    Anticancer Drugs; 2023 Nov; 34(10):1122-1131. PubMed ID: 37067993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer.
    Liu G; Bollig-Fischer A; Kreike B; van de Vijver MJ; Abrams J; Ethier SP; Yang ZQ
    Oncogene; 2009 Dec; 28(50):4491-500. PubMed ID: 19784073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches.
    Varghese B; Del Gaudio N; Cobellis G; Altucci L; Nebbioso A
    Front Oncol; 2021; 11():750315. PubMed ID: 34778065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of KDM4 lysine demethylases disrupts the integrity of the DNA mismatch repair pathway.
    Awwad SW; Ayoub N
    Biol Open; 2015 Mar; 4(4):498-504. PubMed ID: 25770186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling KDM4 histone demethylase expression and its association with adverse cytogenetic findings in chronic lymphocytic leukemia.
    Filiú-Braga LDC; Serejo TRT; Lucena-Araujo AR; Neves FAR; de Carvalho JL; Rego EM; Saldanha-Araujo F
    Med Oncol; 2018 Nov; 36(1):3. PubMed ID: 30426231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Novel Benzimidazole Pyrazolone Scaffold That Inhibits KDM4 Lysine Demethylases and Reduces Proliferation of Prostate Cancer Cells.
    Carter DM; Specker E; Przygodda J; Neuenschwander M; von Kries JP; Heinemann U; Nazaré M; Gohlke U
    SLAS Discov; 2017 Aug; 22(7):801-812. PubMed ID: 28346812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heme, A Metabolic Sensor, Directly Regulates the Activity of the KDM4 Histone Demethylase Family and Their Interactions with Partner Proteins.
    Konduri PC; Wang T; Salamat N; Zhang L
    Cells; 2020 Mar; 9(3):. PubMed ID: 32235736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzo[
    Kim YJ; Lee DH; Choi YS; Jeong JH; Kwon SH
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KDM4 Demethylases: Structure, Function, and Inhibitors.
    Jiang Y; Liu L; Yang ZQ
    Adv Exp Med Biol; 2023; 1433():87-111. PubMed ID: 37751137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.
    Qiu MT; Fan Q; Zhu Z; Kwan SY; Chen L; Chen JH; Ying ZL; Zhou Y; Gu W; Wang LH; Cheng WW; Zeng J; Wan XP; Mok SC; Wong KK; Bao W
    Oncotarget; 2015 Oct; 6(31):31702-20. PubMed ID: 26397136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KDM4 inhibitor SD49-7 attenuates leukemia stem cell
    Li Y; Wang C; Gao H; Gu J; Zhang Y; Zhang Y; Xie M; Cheng X; Yang M; Zhang W; Li Y; He M; Xu H; Zhang H; Ji Q; Ma T; Ding S; Zhao Y; Gao Y
    Theranostics; 2022; 12(11):4922-4934. PubMed ID: 35836814
    [No Abstract]   [Full Text] [Related]  

  • 19. The Diverse Roles of Histone Demethylase KDM4B in Normal and Cancer Development and Progression.
    Wang Z; Cai H; Zhao E; Cui H
    Front Cell Dev Biol; 2021; 9():790129. PubMed ID: 35186950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide Kdm4 histone demethylase transcriptional regulation in Drosophila.
    Tsurumi A; Xue S; Zhang L; Li J; Li WX
    Mol Genet Genomics; 2019 Oct; 294(5):1107-1121. PubMed ID: 31020413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.